BEQGX
Price
$40.39
Change
+$0.38 (+0.95%)
Updated
Sep 11 closing price
Net Assets
1.96B
VFFSX
Price
$375.42
Change
+$3.22 (+0.87%)
Updated
Sep 11 closing price
Net Assets
1.76T
Interact to see
Advertisement

BEQGX vs VFFSX

BEQGX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
BEQGX vs. VFFSX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEQGX is a StrongBuy and VFFSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.76T vs. BEQGX (1.96B). VFFSX pays higher dividends than BEQGX: VFFSX (1.05) vs BEQGX (0.44). BEQGX was incepted earlier than VFFSX: BEQGX (35 years) vs VFFSX (10 years). BEQGX (0.65) is less costly to investors than VFFSX (0.01). BEQGX is a more actively managed with annual turnover of: 73.00 vs. VFFSX (2.00). BEQGX has a lower initial minimum investment than VFFSX: BEQGX (2500) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 15.26 vs. BEQGX (9.29). VFFSX return over 5 years is better than : 70.49 vs. BEQGX (10.58).
BEQGXVFFSXBEQGX / VFFSX
Total Expense Ratio0.650.016,500%
Annual Report Gross Expense Ratio0.650.016,500%
Fund Existence35 years10 years-
Gain YTD13.77211.121124%
Front LoadN/AN/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.96B1.76T0%
Annual Yield % from dividends0.441.0542%
Returns for 1 year9.2915.2661%
Returns for 3 years64.2770.3391%
Returns for 5 years10.5870.4915%
Returns for 10 years58.35258.6323%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EVX39.940.34
+0.85%
VanEck Environmental Svcs ETF
XTN102.410.55
+0.54%
State Street® SPDR® S&PTrsptnETF
RCLR51.670.02
+0.04%
Reckoner BBB-B Clo Reinvesting ETF
CPNS28.33N/A
+0.01%
Calamos Nasdaq-100 Str Alt Prt ETF-Sep
IHE101.07-0.20
-0.20%
iShares US Pharmaceuticals ETF